Amgen Inc (NASDAQ:AMGN)

153.26
Delayed Data
As of Jul 02
 -1.73 / -1.12%
Today’s Change
114.93
Today|||52-Week Range
173.60
-3.79%
Year-to-Date

Today’s Trading

Previous close154.99
Today’s open155.15
Day’s range153.01 - 155.57
Volume2,120,917
Average volume (3 months)3,185,946
Market cap$116.7B
Dividend yield2.06%
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+9.89%
Earnings growth (next 5 years)+10.46%
Revenue growth (last year)+7.30%
P/E ratio20.7
Price/Sales6.12
Price/Book4.53

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-1.13-0.28%
GILDGilead Sciences-0.97-0.84%
BAXBaxter International...-0.56-1.44%
BLUEbluebird bio Inc+0.14+0.09%
Data as of 4:02pm ET, 07/02/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$2.41
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers